Nobel Biocare Profits Down – Still Expects Growth for 2008

Nobel held their 2nd quarter earnings call today. Here’s a summary of the report (click here for the full interim report):

  • Earnings for Q2 down 42% versus Q2 2007
  • Their shares have lost 40% so far this year
  • CEO Domenico Scala cites that NobelActive has been helpful in regaining customer’s trust in their product
  • The Asian market has stalled due to delayed approval of the NobelSpeedy™ line
  • Scala also states that many experienced reps have joined or returned to Nobel’s sales force

Okay – I think that’s enough financial talk. When the transcript is published on Seeking Alpha, I’ll post the link.

Read The Dental Implant Blog…

Published in: on August 12, 2008 at 2:32 am Leave a Comment

The URI to TrackBack this entry is: http://implantblog.wordpress.com/2008/08/12/nobel-biocare-profits-down-still-expects-growth-for-2008/trackback/

RSS feed for comments on this post.

Leave a Comment